Cite
MLA Citation
Rashmi Murthy et al.. “Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.” Lancet oncology, vol. 19, no. 7, 2018, pp. 880–888. http://access.bl.uk/ark:/81055/vdc_100066429082.0x00000d